UroGen Pharma Ltd. (URGN) Faces Securities Class Action Amid FDA's Briefing Document and Subsequent ODAC Vote Against UGN-102– H

• click to rate

  Posted by Two Blokes Jun 7 - Filed in Stock - 8 views
  
  SAN FRANCISCO, June 06, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit styled Cockrell v. UroGen Pharma Ltd.